Search

Happy New year - and UPDATED COVID-19 treatment guidelines!

With the New Year, new guidelines! Our COVID-19 therapeutic working group has revised our COVID-19 management guidelines. Of note, empiric antibiotics are strongly DISCOURAGED for mild and moderate disease. Investigational or off-label therapies should NOT be given outside of clinical trials (several ongoing clinical trials at the MUHC); Criteria are proposed for potential identification of hyperimmune response, with recommendations to consult ID for severe cases.



16 views0 comments

Recent Posts

See All

MUHC ASP Annual Report 2019-2020 now available!

In this document we provide a detailed account of (among others): - Clinical activities in the past year - Antimicrobial use/expenditures within the MUHC - Priorities for 2021-2022 See in "Resources"

NEW obstetrics-gynecology guidelines!

Hi all, we're pleased to present the following new ob-gyn guidelines: postpartum endometritis, chorioamnionitis, vulvovaginitis/cervicitis/PID - a joint collaboration between ASP and the MUHC Ob-gyn D

Check out updates to COVID-19 management guideline!

Our guideline working group has reviewed latest evidence and recommends therapeutic anticoagulation (instead of prophylactic) for mild and moderate COVID-19. This is based on review of latest evidence

+1 514-934-1934

1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada